1
Return

Affinity-driven epirubicin prodrug albumin nanoassemblies for cancer therapy

delete2026-07-20
delete0
PRE
AI
Y
Yuxin Ma
Y
Yashi Zhan
J
Jiakun Cui
J
Jialin Xing
J
Jiaqi Ma
B
Bingjun Sun *
李凌霄 cover
李凌霄 (Lingxiao Li) *
DOI：10.1016/j.nantod.2026.103126delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
• Generalizable strategy for albumin-based nanomedicine design. • Affinity-driven prodrug enables robust albumin nanoassembly. • Mechanistic insight into overcoming weak drug–albumin interactions. • pH-responsive release enables tumor-selective activation. • Translational nanoplatform enhances pharmacokinetics and therapeutic index.

Journal

Nano Today cover
Nano Today
IF:
10.9
Papers:
3.0K
Citations:
2.1W

Organization

S
shenyang pharmaceutical university
Scholars:
1.4K
Papers: 300
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers